BioCorRx Inc
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; an… Read more
BioCorRx Inc (BICX) - Net Assets
Latest net assets as of September 2025: $-12.76 Million USD
Based on the latest financial reports, BioCorRx Inc (BICX) has net assets worth $-12.76 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($7.53 Million) and total liabilities ($20.30 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-12.76 Million |
| % of Total Assets | -169.43% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
BioCorRx Inc - Net Assets Trend (2014–2024)
This chart illustrates how BioCorRx Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BioCorRx Inc (2014–2024)
The table below shows the annual net assets of BioCorRx Inc from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-12.36 Million | -24.14% |
| 2023-12-31 | $-9.95 Million | -21.35% |
| 2022-12-31 | $-8.20 Million | -17.82% |
| 2021-12-31 | $-6.96 Million | -65.34% |
| 2020-12-31 | $-4.21 Million | -297.62% |
| 2019-12-31 | $-1.06 Million | +81.44% |
| 2018-12-31 | $-5.71 Million | -46.58% |
| 2017-12-31 | $-3.89 Million | +52.12% |
| 2016-12-31 | $-8.13 Million | -147.66% |
| 2015-12-31 | $-3.28 Million | -1171.76% |
| 2014-12-31 | $306.30K | -- |
Equity Component Analysis
This analysis shows how different components contribute to BioCorRx Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7464424900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $71.09 Million | % |
| Total Equity | $-12.12 Million | 100.00% |
BioCorRx Inc Competitors by Market Cap
The table below lists competitors of BioCorRx Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Arad Ltd
TA:ARD
|
$3.25 Million |
|
Axel Ree Ltd
AU:AXL
|
$3.25 Million |
|
KWESST Micro Systems Inc. Common Stock
NASDAQ:KWE
|
$3.25 Million |
|
SAMYUNG ENC Co. Ltd
KQ:065570
|
$3.25 Million |
|
XAU Resources Inc.
V:GIG
|
$3.25 Million |
|
Obm Drilchem PT
JK:OBMD
|
$3.25 Million |
|
Phoslock Environmental Technologies Ltd
AU:PET
|
$3.25 Million |
|
CHUWIT FARM (2019) PUBLIC COMPANY LIMITED
BK:CFARM
|
$3.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BioCorRx Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -9,823,690 to -12,120,420, a change of -2,296,730.
- Net loss of 5,106,124 reduced equity.
- Other factors increased equity by 2,809,394.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-5.11 Million | -42.13% |
| Other Changes | $2.81 Million | +23.18% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares BioCorRx Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $-1.59 | $0.35 | x |
| 2018-12-31 | $-2.17 | $0.35 | x |
| 2019-12-31 | $-0.18 | $0.35 | x |
| 2020-12-31 | $-0.77 | $0.35 | x |
| 2021-12-31 | $-1.02 | $0.35 | x |
| 2022-12-31 | $-1.05 | $0.35 | x |
| 2023-12-31 | $-1.13 | $0.35 | x |
| 2024-12-31 | $-0.91 | $0.35 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BioCorRx Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -66616.10%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-97.95%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -1077.43% | -267.12% | 0.29x | 14.07x | $-3.16 Million |
| 2015 | 0.00% | -504.58% | 0.66x | 0.00x | $-4.34 Million |
| 2016 | 0.00% | -841.30% | 1.49x | 0.00x | $-5.09 Million |
| 2017 | 0.00% | -4519.55% | 1.94x | 0.00x | $-29.32 Million |
| 2018 | 0.00% | -1728.87% | 0.60x | 0.00x | $-5.95 Million |
| 2019 | 0.00% | -2513.80% | 0.06x | 0.00x | $-5.94 Million |
| 2020 | 0.00% | -2859.63% | 0.07x | 0.00x | $-3.09 Million |
| 2021 | 0.00% | -10789.39% | 0.06x | 0.00x | $-4.52 Million |
| 2022 | 0.00% | -2043.30% | 0.28x | 0.00x | $-3.56 Million |
| 2023 | 0.00% | -4224.89% | 0.23x | 0.00x | $-2.78 Million |
| 2024 | 0.00% | -66616.10% | 0.02x | 0.00x | $-3.89 Million |
Industry Comparison
This section compares BioCorRx Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BioCorRx Inc (BICX) | $-12.76 Million | -1077.43% | N/A | $3.25 Million |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |